# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-24-057429
Filing Date
2024-05-10
Accepted
2024-05-10 06:09:04
Documents
28
Period of Report
2024-05-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | acet-20240510.htm iXBRL | 8-K | 40925
2 | EX-99.1 | acet-ex99_1.htm | EX-99.1 | 9700
3 | GRAPHIC | acet-ex99_1s1.jpg | GRAPHIC | 499906
4 | GRAPHIC | acet-ex99_1s2.jpg | GRAPHIC | 352562
5 | GRAPHIC | acet-ex99_1s3.jpg | GRAPHIC | 691178
6 | GRAPHIC | acet-ex99_1s4.jpg | GRAPHIC | 401821
7 | GRAPHIC | acet-ex99_1s5.jpg | GRAPHIC | 469370
8 | GRAPHIC | acet-ex99_1s6.jpg | GRAPHIC | 403291
9 | GRAPHIC | acet-ex99_1s7.jpg | GRAPHIC | 432980
10 | GRAPHIC | acet-ex99_1s8.jpg | GRAPHIC | 437990
11 | GRAPHIC | acet-ex99_1s9.jpg | GRAPHIC | 399114
12 | GRAPHIC | acet-ex99_1s10.jpg | GRAPHIC | 324824
13 | GRAPHIC | acet-ex99_1s11.jpg | GRAPHIC | 448787
14 | GRAPHIC | acet-ex99_1s12.jpg | GRAPHIC | 470886
15 | GRAPHIC | acet-ex99_1s13.jpg | GRAPHIC | 448083
16 | GRAPHIC | acet-ex99_1s14.jpg | GRAPHIC | 754437
17 | GRAPHIC | acet-ex99_1s15.jpg | GRAPHIC | 412737
18 | GRAPHIC | acet-ex99_1s16.jpg | GRAPHIC | 313291
| Complete submission text file | 0000950170-24-057429.txt |  | 10167100

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
19 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | acet-20240510.xsd | EX-101.SCH | 25037
32 | EXTRACTED XBRL INSTANCE DOCUMENT | acet-20240510_htm.xml | XML | 4753

Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 24932741
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)